Effects of Tamoxifen and Ethynylestradiol on Uterine Growth in Mice
Author Information
Author(s): Cora J. Fong, Lyle D. Burgoon, Kurt J. Williams, Agnes L. Forgacs, Timothy R. Zacharewski
Primary Institution: Michigan State University
Hypothesis
The study aims to compare the uterine effects of tamoxifen and ethynylestradiol in immature, ovariectomized mice.
Conclusion
Tamoxifen and ethynylestradiol induce similar gene expression profiles, but tamoxifen shows lower efficacy and unique responses compared to ethynylestradiol.
Supporting Evidence
- Tamoxifen treatment resulted in a significant increase in uterine wet weight after three daily doses.
- Gene expression analysis identified 2235 differentially expressed genes following tamoxifen treatment.
- Tamoxifen responses exhibited a delayed increase in uterine weight compared to ethynylestradiol.
- Functional annotation of differentially expressed genes was associated with cell growth and proliferation.
Takeaway
This study looked at how two drugs, tamoxifen and ethynylestradiol, affect the growth of the uterus in mice. It found that while both drugs have similar effects, tamoxifen is not as strong as ethynylestradiol.
Methodology
The study used a uterotrophic assay to evaluate the effects of tamoxifen and ethynylestradiol on uterine weight and gene expression in ovariectomized mice.
Limitations
The study's findings may not fully translate to human physiology due to differences in drug metabolism between species.
Participant Demographics
Immature, ovariectomized C57BL/6 mice
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website